Rachel Smith is an ultra-rare disease subject matter expert with over 10 years of experience in clinical research, sponsor, and CRO roles across APAC, Europe, and North America. She oversees 30+ multimillion-dollar orphan disease programs funded by both sponsors and academic institutions. Rachel has led or overseen more than 40 Phase I-IV clinical trials across pediatric, adolescent, and adult populations, specializing in rare diseases.